Catalysts for Rinvoq
19 tracked
Oct 10, 2025
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Aug 12, 2025
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Apr 28, 2025
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Mar 26, 2025
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Apr 26, 2024
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Apr 26, 2024
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Nov 14, 2023
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Jun 22, 2023
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
May 18, 2023
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Apr 10, 2023
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Oct 21, 2022
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Apr 29, 2022
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Mar 16, 2022
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Jan 14, 2022
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Dec 14, 2021
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Dec 14, 2021
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Dec 2, 2021
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Jul 10, 2020
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Aug 16, 2019
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→